Professional comparison
Two compact saliva tests, but configurations and uses to verify
The Drugdiag® Saliva Innovation 5+ and the Dräger DrugCheck® 3000 are single-use saliva screening devices. The right choice depends less on a general ranking than on the substances sought, the threshold of the purchased configuration, internal procedures, and traceability needs.
Key point: a rapid test result is preliminary. In an official, medical, disciplinary, or disputed context, analytical confirmation may be necessary.
Drugdiag® Saliva Innovation 5+
Toda Pharma reference 1045-SAL-025, designed to detect five families in saliva with a removable strip.
- THC: 15 ng/mL
- Amphetamines: 50 ng/mL
- Methamphetamines: 50 ng/mL
- Cocaine: 10 ng/mL
- Opiates: 10 ng/mL
- Reading announced by Toda Pharma: 5 minutes
Dräger DrugCheck® 3000
Compact saliva test without power supply, offered with several configurations depending on the market and substances sought.
- Up to seven substance classes depending on the version
- Announced measurement time: 3 to 5 minutes
- Saliva sampling indicator
- Visual reading and Dräger add app available depending on equipment
- Thresholds to check on the exact reference and its instructions
Useful comparison before purchase
ConfigurationDrugdiag: five panels defined on reference 1045-SAL-025.Dräger: number of classes and thresholds vary according to configuration.
SamplingDrugdiag: removable strip integrated into the device.Dräger: saliva collector with sampling indicator.
Reading timeDrugdiag: 5 minutes according to the Toda Pharma catalog.Dräger: 3 to 5 minutes depending on the manufacturer.
Digital traceabilityDrugdiag: visual reading of the device.Dräger: optional app to read and save results depending on the configuration.
French road frameworkThe Drugdiag reference covers the four families sought by the order of December 13, 2016.Compliance must be assessed on the exact Dräger configuration and its instructions.
How to choose without oversimplifying?
First choose the configuration, not just the brand. Check the list of panels, thresholds, reading time, storage conditions, shelf life, and the confirmation procedure planned in case of a positive result.
For a company, the device must be part of a proportionate procedure, known in advance and respectful of confidentiality. The employer’s general safety obligation does not, by itself, create a universal obligation to screen all employees.
Need a saliva test with five defined panels?
Check the Drugdiag® Saliva Innovation 5+ datasheet for available formats, batch instructions, and professional conditions.
Sources and limits of the comparison
Drugdiag® features: Toda Pharma 2024 catalog and product reference 1045-SAL-025. Dräger features: official DrugCheck® 3000 documentation. Road framework: order of December 13, 2016 in force. Manufacturers may offer several configurations; the instructions for the actually delivered reference take precedence.
Official Dräger documentation · Order of December 13, 2016 on Légifrance